# Study of Oncoimmunome for the Treatment of Stage III/IV Ovarian Carcinoma

> **NCT02933073** · PHASE1 · TERMINATED · sponsor: **UConn Health** · enrollment: 8 (actual)

## Conditions studied

- Ovarian Cancer

## Interventions

- **BIOLOGICAL:** OncoImmunome

## Key facts

- **NCT ID:** NCT02933073
- **Lead sponsor:** UConn Health
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-11
- **Primary completion:** 2022-08
- **Final completion:** 2022-08
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Study recruitment is temporary on hold by the sponsor due to patient recruitment challenges and the ongoing review of the investigational adjuvant.
- **Last updated:** 2022-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02933073

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02933073, "Study of Oncoimmunome for the Treatment of Stage III/IV Ovarian Carcinoma". Retrieved via AI Analytics 2026-08-23 from https://api.ai-analytics.org/clinical/NCT02933073. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*